Already the nation’s leading university for medical research, UCSF continues to expand thanks to a generous and recent donation.Read More
California is home to some serious unicellular research, and the National Institute of Health is taking notice. Bioresearch programs at California institutions accounted for a significant portion of the $7.9 million in grants which the NIH awarded to researchers studying single cells. The request for 2014 applications came from the NIH last December to fund programs related to many areas of cellular biology, including personalized treatment for diseases at a cellular level. The grants are supported by the NIH Common Fund’s Single Cell Analysis Program (SCAP) and represents a major boost for many of the 25 research teams that were chosen to receive funding.Read More
Once a stigmatized disease, AIDS is now a primary focus for many researchers seeking to address deadly health problems and potentially save the lives of millions of men, women and children. AIDS killed 1.5 million people worldwide last year, a staggering number that has drawn the attention of the Bill & Melinda Gates Foundation. Addressing this disease is a priority for the Gates Foundation, as is evidenced by all the work they have done to select and fund promising research. Fortunately, scientists all over the world are searching for innovative solutions to curing this disease. The Gates Foundation has found one likely contender for a vaccine that may also work as a cure in the work of a science researcher at Oregon Health and Science University.
It has been a good year for University of Texas at Austin researchers in terms of new research funding: At least three studies have received upwards of $650,000 in life science funding from the National Institutes of Health. “Remodeling Potential of the Mitral Valve Following Surgical Repair,” the highest NIH-funded life science study so far this year, received $1.3 million. Additionally, “Training Interventions and Genetics of Exercise Response” and “Novel Molecular and Cellular Approaches for Alcoholism Medication Development” received $684,724 and $664,347 respectively.
Oregon Health and Science University along with two other public Oregon schools recently opened a new life sciences building, the state’s largest academic building, on Portland’s South Waterfront. The project received $110 million in life science funding from taxpayers, $92 million in funding from Oregon Health and Science University institutional funding, $83 million from OHSU philanthropy and $10 million from the TriMet regional mass transit agency. The riverfront property for the new research building was donated by the Schnitzer family to help OHSU increase its campus presence in Portland.
A new research building is in its planning stages at the University of California, Riverside according to Kim A. Wilcox, chancellor of UC Riverside. In a formal Investiture ceremony on the University of California, Riverside campus, Wilcox made remarks highlighting the university’s plans to increase the number of research lab scientists working on campus, add a new research building to the UC Riverside campus, and achieve increased globalization.
Researchers at the University of California, Santa Barbara recently conducted a study on fruit flies that shows that diet experience can alter taste preference. This finding has been speculated about before, but its implications now are important because taste preference is essential for survival when animals and humans are forced to respond to changing sources of food. The researchers exposed fruit flies to camphor, which the fruit flies disliked, and which caused a reduction in the response by the Transient Receptor Potential-Like (TRPL) channel. The degredation of the TRPL protein by an enzyme called E3 ubiquitin ligase, or Ube3a, caused a reduction in the fruit flie’s distaste for camphor.
Texas A&M University at College station recently received a major influx of new life science funding for multidisciplinary quantum biophotonics research. The University was awarded $10.8 million from the Texas A&M University System. This new life science research funding will primarily be used to purchase new biophotonics laboratory equipment.
Researchers at Harvard University have recently published the results of a human clinical trial of a therapeutic that could increase the chances of success for blood stem cell transplantation. This will be the first time that the Harvard Stem Cell Institute has brought a discovery from the lab through clinical trials, marking the success of Harvard’s nine year-old goal of conducting groundbreaking research through the institute.